It has been recently discovered that the use of a TLR4 agonist promotes higher survival rate and decreases parasite burdens in BALB/c mice acutely infected with T. cruzi, although cardiac damage was not prevented92, thus shedding light on how miR-146b-5p is hampering infection of cells and decreasing parasite load. This evidence concerns the gene TLR4 and infection.